Your browser doesn't support javascript.
Decline of RSV-specific antibodies during the COVID-19 pandemic.
den Hartog, Gerco; van Kasteren, Puck B; Schepp, Rutger M; Teirlinck, Anne C; van der Klis, Fiona R M; van Binnendijk, Robert S.
  • den Hartog G; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands. Electronic address: gerco.den.hartog@rivm.nl.
  • van Kasteren PB; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
  • Schepp RM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
  • Teirlinck AC; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
  • van der Klis FRM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
  • van Binnendijk RS; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
Lancet Infect Dis ; 2022 Dec 01.
Article in English | MEDLINE | ID: covidwho-2262332
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article